News about Biotechnology

A study shows how AI technology on clinical decision system can help India in primary and secondary healthcare

A study shows how AI technology on clinical decision system can help India in primary and secondary healthcare

An integrated clinical decision support system (CDSS) using artificial intelligence (AI) could be useful to health workers in primary and secondary healthcare settings to overcome the present challenges including a lack of adequate manpower in the system, according to a study sponsored by NITI Aayog and UK-Department of International Trade

Biotechnology | 01/09/2021 | By Darshana

Nucleome unveils South Asia's largest genomics research centre in Hyderabad

Nucleome unveils South Asia's largest genomics research centre in Hyderabad

In a move that will mark the beginning of a new era in India?s genomics capability, Nucleome Informatics has unveiled South Asia?s largest and most advanced genomics facility, NKC Centre for Genomics Research in Hyderabad

Biotechnology | 27/08/2021 | By Darshana

Sana Biotech obtains non-exclusive clinical & commercial rights to use MaxCyte's Flow Electroporation technology and ExPERT platform

Sana Biotech obtains non-exclusive clinical & commercial rights to use MaxCyte's Flow Electroporation technology and ExPERT platform

MaxCyte, Inc., a leading provider of cell-engineering platform technologies, announced the signing of a clinical and commercial license with Sana Biotechnology, Inc., a company focused on creating and delivering engineered cells as medicines<br />

Biotechnology | 10/08/2021 | By Darshana

Pharmexcil seeks list of products requiring SION norms fixation from exporters

Pharmexcil seeks list of products requiring SION norms fixation from exporters

The Pharmaceutical Export Promotion Council of India (Pharmexcil) has asked exporters to provide a list of products requiring Standard Input Output Norms (SION) fixation to help them fulfill export obligations in a timely manner

Biotechnology | 02/08/2021 | By Darshana

Ascentage, Innovent Biologics ink pact to commercialize olverembatinib in China and joint clinical development of lisaftoclax

Ascentage, Innovent Biologics ink pact to commercialize olverembatinib in China and joint clinical development of lisaftoclax

Ascentage Pharma and Innovent Biologics announced a multifaceted strategic collaboration. This collaboration includes the joint clinical development and commercialization of HQP1351(olverembatinib), a third-generation BCR-ABL inhibitor and a core drug candidate of Ascentage Pharma

Biotechnology | 16/07/2021 | By Darshana

Abbott gets CDSCO approval for marketing of estradiol, dydrogesterone FDC

Abbott gets CDSCO approval for marketing of estradiol, dydrogesterone FDC

Abbott, the global healthcare company, has received approval from the Subject Expert Committee (SEC) at Central Drugs Standard Control Organisation (CDSCO) for importing and marketing of the fixed dose combination of dydrogesterone+estradiol (2.5 mg + 0.5mg) tablets

Biotechnology | 15/07/2021 | By Darshana

Lupin gets US FDA nod to market generic Kerydin topical solution

Lupin gets US FDA nod to market generic Kerydin topical solution

Global pharma major Lupin Limited announced the US launch of tavaborole topical solution, 5% having received an approval from the United States Food and Drug Administration (FDA)

Biotechnology | 13/07/2021 | By Darshana

IGBA launches a whitepaper: A vision for the generic and biosimilar medicines industry

IGBA launches a whitepaper: A vision for the generic and biosimilar medicines industry

The International Generic and Biosimilar Medicines Association (IGBA) has announced the launch of a whitepaper: A vision for the generic and biosimilar medicines industry, which covers the strong contribution of this pharmaceutical sector to global health outcomes and economies, the opportunities, challenges and disruptions for the industry

Biotechnology | 08/07/2021 | By Darshana

CGT Catapult to expand to Edinburgh BioQuarter to speed up product development

CGT Catapult to expand to Edinburgh BioQuarter to speed up product development

The Cell and Gene Therapy Catapult (CGT Catapult), an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, by bridging the gap between scientific research and full-scale commercialisation

Biotechnology | 02/07/2021 | By Darshana

Alembic Pharma receives US FDA approval for generic Macrodantin capsules

Alembic Pharma receives US FDA approval for generic Macrodantin capsules

Alembic Pharmaceuticals Limited announced that it has received final approval from the US Food & Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for nitrofurantoin capsules, USP (Macrocrystals), 25 mg, 50 mg and 100 mg

Biotechnology | 01/07/2021 | By Darshana

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology